American Lung Association Offers Support to Help People Quit All Nicotine and Tobacco Products

 


Currently, 16.4% of adults in the US use at least one tobacco or nicotine product such as cigarettes, E-cigarettes or nicotine pouches. Nicotine is extremely addictive, so the American Lung Association is offering free resources and support to help people quit tobacco and nicotine products for good.

Tobacco use remains the leading cause of preventable death and disease in America, killing 490,000 people each year. Currently, 16 million Americans live with a tobacco-related disease. While it's best to quit as early as possible, quitting tobacco and nicotine products at any age will enhance the length and quality of life.

"Breaking the addiction to nicotine is extremely difficult. For most people, it takes multiple attempts to quit tobacco for good. Each quit attempt brings a person closer to reaching their goal," said Harold Wimmer, President and CEO of the American Lung Association. "While smoking rates have decreased significantly over the past 50 years, we are concerned about more adults and youth using e-cigarettes and nicotine pouches. It is critical that people who are ready to quit using nicotine and tobacco products speak with their healthcare provider about Food and Drug Administration (FDA)-approved tobacco treatment medications."

The American Lung Association offers a free Lung Helpline to help people get started on their journey to quit. People can call 1-800-LUNGUSA to connect with a licensed registered nurse, respiratory therapist or certified tobacco treatment specialist. Services to help people quit nicotine and tobacco are available for adults and also teens ages 13 and up. The Lung Helpline also offers programmes to employers to help their employees quit.

In addition, the Lung Helpline can help assist with information about lung cancer screening if they are eligible, help navigate insurance challenges, and connect people with Lung Health Navigators who specialise in lung cancer, asthma, chronic obstructive pulmonary disease and pulmonary fibrosis.

Read more on Global Policy

Read more in Sustainability

Read more in Technology and Society

Read more in Society